Europe Urological Cancer Therapeutics Drugs Market Report 2017

Europe Urological Cancer Therapeutics Drugs Market Report 2017

1 Urological Cancer Therapeutics Drugs Overview

1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs

1.2 Classification of Urological Cancer Therapeutics Drugs

1.2.1 Xofigo (radium Ra 223 dichloride)

1.2.2 Jevtana (cabazitaxel)

1.2.3 Inlyta (axitinib)

1.2.4 Votrient (pazopanib hydrochloride)

1.2.5 Sutent (sunitinib malate)

1.2.6 Zytiga (abiraterone acetate)

1.2.7 Xtandi (enzalutamide)

1.2.8 Opdivo (nivolumab)

1.2.9 Provenge (sipuleucel-T)

1.3 Application of Urological Cancer Therapeutics Drugs

1.3.1 Hospital

1.3.2 Medical Research Laboratory

1.3.3 Others

1.4 Urological Cancer Therapeutics Drugs Market by Countries

1.4.1 Germany Status and Prospect (2012-2022)

1.4.2 France Status and Prospect (2012-2022)

1.4.3 UK Status and Prospect (2012-2022)

1.4.4 Russia Status and Prospect (2012-2022)

1.4.5 Italy Status and Prospect (2012-2022)

1.4.6 Spain Status and Prospect (2012-2022)

1.4.7 Benelux Status and Prospect (2012-2022)

1.5 Europe Market Size (Value and Volume) of Urological Cancer Therapeutics Drugs (2012-2022)

1.5.1 Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)

1.5.2 Europe Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

2 Europe Urological Cancer Therapeutics Drugs by Manufacturers, Type and Application

2.1 Europe Urological Cancer Therapeutics Drugs Market Competition by Manufacturers

2.1.1 Europe Urological Cancer Therapeutics Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Urological Cancer Therapeutics Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Urological Cancer Therapeutics Drugs (Volume and Value) by Type

2.2.1 Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)

2.3 Europe Urological Cancer Therapeutics Drugs (Volume and Value) by Countries

2.3.1 Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Countries (2012-2017)

2.3.2 Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Countries (2012-2017)

2.4 Europe Urological Cancer Therapeutics Drugs (Volume) by Application

3 Germany Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

3.1 Germany Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

3.1.1 Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

3.1.2 Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

3.1.3 Germany Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

3.2 Germany Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

3.3 Germany Urological Cancer Therapeutics Drugs Sales and Market Share by Type

3.4 Germany Urological Cancer Therapeutics Drugs Sales and Market Share by Application

4 France Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

4.1 France Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

4.1.1 France Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

4.1.2 France Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

4.1.4 France Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

4.2 France Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

4.3 France Urological Cancer Therapeutics Drugs Sales and Market Share by Type

4.4 France Urological Cancer Therapeutics Drugs Sales and Market Share by Application

5 UK Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

5.1 UK Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

5.1.1 UK Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

5.1.2 UK Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

5.1.5 UK Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

5.2 UK Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

5.3 UK Urological Cancer Therapeutics Drugs Sales and Market Share by Type

5.4 UK Urological Cancer Therapeutics Drugs Sales and Market Share by Application

6 Russia Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

6.1 Russia Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

6.1.1 Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

6.1.2 Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

6.1.6 Russia Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

6.2 Russia Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

6.3 Russia Urological Cancer Therapeutics Drugs Sales and Market Share by Type

6.4 Russia Urological Cancer Therapeutics Drugs Sales and Market Share by Application

7 Italy Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

7.1 Italy Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

7.1.1 Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

7.1.2 Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

7.1.7 Italy Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

7.2 Italy Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

7.3 Italy Urological Cancer Therapeutics Drugs Sales and Market Share by Type

7.4 Italy Urological Cancer Therapeutics Drugs Sales and Market Share by Application

8 Spain Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

8.1 Spain Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

8.1.1 Spain Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

8.1.2 Spain Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

8.1.8 Spain Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

8.2 Spain Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

8.3 Spain Urological Cancer Therapeutics Drugs Sales and Market Share by Type

8.4 Spain Urological Cancer Therapeutics Drugs Sales and Market Share by Application

9 Benelux Urological Cancer Therapeutics Drugs (Volume, Value and Sales Price)

9.1 Benelux Urological Cancer Therapeutics Drugs Sales and Value (2012-2017)

9.1.1 Benelux Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

9.1.2 Benelux Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

9.1.9 Benelux Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

9.2 Benelux Urological Cancer Therapeutics Drugs Sales and Market Share by Manufacturers

9.3 Benelux Urological Cancer Therapeutics Drugs Sales and Market Share by Type

9.4 Benelux Urological Cancer Therapeutics Drugs Sales and Market Share by Application

10 Europe Urological Cancer Therapeutics Drugs Manufacturers Analysis

10.1 Novartis

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.1.2.1 Xofigo (radium Ra 223 dichloride)

10.1.2.2 Jevtana (cabazitaxel)

10.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.1.4 Main Business/Business Overview

10.2 Pfizer

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.2.2.1 Xofigo (radium Ra 223 dichloride)

10.2.2.2 Jevtana (cabazitaxel)

10.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.2.4 Main Business/Business Overview

10.3 Johnson & Johnson

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.3.2.1 Xofigo (radium Ra 223 dichloride)

10.3.2.2 Jevtana (cabazitaxel)

10.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.3.4 Main Business/Business Overview

10.4 AstraZeneca

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.4.2.1 Xofigo (radium Ra 223 dichloride)

10.4.2.2 Jevtana (cabazitaxel)

10.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.4.4 Main Business/Business Overview

10.5 Astellas

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.5.2.1 Xofigo (radium Ra 223 dichloride)

10.5.2.2 Jevtana (cabazitaxel)

10.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.5.4 Main Business/Business Overview

10.6 Bristol-Myers Squibb

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.6.2.1 Xofigo (radium Ra 223 dichloride)

10.6.2.2 Jevtana (cabazitaxel)

10.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.6.4 Main Business/Business Overview

10.7 Abbott Laboratories

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.7.2.1 Xofigo (radium Ra 223 dichloride)

10.7.2.2 Jevtana (cabazitaxel)

10.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.7.4 Main Business/Business Overview

10.8 Celgene Corporation

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.8.2.1 Xofigo (radium Ra 223 dichloride)

10.8.2.2 Jevtana (cabazitaxel)

10.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.8.4 Main Business/Business Overview

10.9 Dendreon Corporation

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.9.2.1 Xofigo (radium Ra 223 dichloride)

10.9.2.2 Jevtana (cabazitaxel)

10.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.9.4 Main Business/Business Overview

10.10 Ferring Pharmaceuticals

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Urological Cancer Therapeutics Drugs Product Type, Application and Specification

10.10.2.1 Xofigo (radium Ra 223 dichloride)

10.10.2.2 Jevtana (cabazitaxel)

10.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

10.10.4 Main Business/Business Overview

10.11 GlaxoSmithKline plc

10.12 Indevus Pharmaceuticals Inc

10.13 Ipsen

10.14 Roche Healthcare

10.15 Sanofi S.A.

11 Urological Cancer Therapeutics Drugs Manufacturing Cost Analysis

11.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Urological Cancer Therapeutics Drugs Market Forecast (2017-2022)

14.1 Germany Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.2 France Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.3 UK Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.4 Russia Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.5 Italy Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.6 Spain Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.7 Benelux Urological Cancer Therapeutics Drugs Sales Forecast (2017-2022)

14.8 Europe Urological Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)

14.9 Europe Urological Cancer Therapeutics Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Urological Cancer Therapeutics Drugs

Table Classification of Urological Cancer Therapeutics Drugs

Figure Europe Sales Market Share of Urological Cancer Therapeutics Drugs by Type in 2015

Figure Xofigo (radium Ra 223 dichloride) Picture

Figure Jevtana (cabazitaxel) Picture

Figure Inlyta (axitinib) Picture

Figure Votrient (pazopanib hydrochloride) Picture

Figure Sutent (sunitinib malate) Picture

Figure Zytiga (abiraterone acetate) Picture

Figure Xtandi (enzalutamide) Picture

Figure Opdivo (nivolumab) Picture

Figure Provenge (sipuleucel-T) Picture

Table Application of Urological Cancer Therapeutics Drugs

Figure Europe Sales Market Share of Urological Cancer Therapeutics Drugs by Application in 2015

Figure Hospital Examples

Figure Medical Research Laboratory Examples

Figure Others Examples

Figure Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure France Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure UK Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure Spain Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure Benelux Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2022)

Figure Europe Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2022)

Table Europe Urological Cancer Therapeutics Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Urological Cancer Therapeutics Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Urological Cancer Therapeutics Drugs Sales Share by Manufacturers

Figure 2016 Urological Cancer Therapeutics Drugs Sales Share by Manufacturers

Table Europe Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers

Table 2016 Europe Urological Cancer Therapeutics Drugs Revenue Share by Manufacturers

Table Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Type (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)

Figure Europe Urological Cancer Therapeutics Drugs Sales Growth Rate by Type (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Type (2012-2017)

Figure Europe Urological Cancer Therapeutics Drugs Revenue Growth Rate by Type (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Countries (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Sales Share by Countries (2012-2017)

Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Countries (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Revenue and Market Share by Countries (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Revenue Share by Countries (2012-2017)

Figure Revenue Market Share of Urological Cancer Therapeutics Drugs by Countries (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Sales and Market Share by Application (2012-2017)

Table Europe Urological Cancer Therapeutics Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Urological Cancer Therapeutics Drugs by Application (2012-2017)

Figure Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure Germany Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table Germany Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table Germany Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table Germany Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table Germany Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure France Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure France Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure France Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table France Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table France Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table France Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table France Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table France Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table France Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure UK Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure UK Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure UK Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table UK Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table UK Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table UK Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table UK Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table UK Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure Russia Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table Russia Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table Russia Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table Russia Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table Russia Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure Italy Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table Italy Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table Italy Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table Italy Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table Italy Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure Spain Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure Spain Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure Spain Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table Spain Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table Spain Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table Spain Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table Spain Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Figure Benelux Urological Cancer Therapeutics Drugs Sales and Growth Rate (2012-2017)

Figure Benelux Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2012-2017)

Figure Benelux Urological Cancer Therapeutics Drugs Sales Price Trend (2012-2017)

Table Benelux Urological Cancer Therapeutics Drugs Sales by Manufacturers (2015 and 2016)

Table Benelux Urological Cancer Therapeutics Drugs Market Share by Manufacturers (2015 and 2016)

Table Benelux Urological Cancer Therapeutics Drugs Sales by Type (2015 and 2016)

Table Benelux Urological Cancer Therapeutics Drugs Market Share by Type (2015 and 2016)

Table Benelux Urological Cancer Therapeutics Drugs Sales by Application (2015 and 2016)

Table Benelux Urological Cancer Therapeutics Drugs Market Share by Application (2015 and 2016)

Table Urological Cancer Therapeutics Drugs Basic Information List

Table Novartis Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table AstraZeneca Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Astellas Basic Information List

Table Astellas Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Astellas Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Abbott Laboratories Basic Information List

Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Dendreon Corporation Basic Information List

Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table Ferring Pharmaceuticals Basic Information List

Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales Market Share (2012-2017)

Table GlaxoSmithKline plc Basic Information List

Table Indevus Pharmaceuticals Inc Basic Information List

Table Ipsen Basic Information List

Table Roche Healthcare Basic Information List

Table Sanofi S.A. Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Urological Cancer Therapeutics Drugs

Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis

Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Manufacturers in 2015

Table Major Buyers of Urological Cancer Therapeutics Drugs

Table Distributors/Traders List

Figure Germany Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure France Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure France Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure UK Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure UK Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Russia Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Italy Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Spain Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Spain Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Figure Benelux Urological Cancer Therapeutics Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Benelux Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Europe Urological Cancer Therapeutics Drugs Sales Forecast by Type (2017-2022)

Table Europe Urological Cancer Therapeutics Drugs Sales Forecast by Application (2017-2022)